Home / Bio-technology / Global Insulin Glargine Market by Manufacturers, Regions, Type and Application, Forecast to 2025

Global Insulin Glargine Market by Manufacturers, Regions, Type and Application, Forecast to 2025

  • Id : RNR-43845
  • Category : Bio-technology
  • Publish Date : 2018
  • Pages : 114
  • Format : PDF
License Type

Description
Insulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).

Scope of the Report:
This report focuses on the Insulin Glargine in Global market, especially in North America, Europe and Asia-Pacific, Latin America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
    Sanofi-Aventis
    Ganlee
    Biocon

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
Latin America, Middle East and Africa

Market Segment by Type, covers
    Single Dose Vial
    Pre-filled Syringe

Market Segment by Applications, can be divided into
    Treat type 1 diabetes
    Treat type 2 diabetes

There are 13 Chapters to deeply display the global Insulin Glargine market.

Chapter 1, to describe Insulin Glargine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Insulin Glargine, with sales, revenue, and price of Insulin Glargine, in 2017 and 2018;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2017 and 2018;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Insulin Glargine, for each region, from 2013 to 2018;

Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 11, Insulin Glargine market forecast, by regions, type and application, with sales and revenue, from 2016 to 2025;

Chapter 12 and 13, to describe Insulin Glargine sales channel, distributors, traders, dealers, appendix and data source.